Petition update"No nos dejes morir asi". PETICION SANIDAD PUBLICA APRUEBE FARMACO CONTRA CANCERES RAROS

Nueva información sobre IVOSIDENIB en colangiocarcinomas metastasicos

antonio jose diaz tossoSeseña, Spain
21 Mar 2022

https://www.cancernetwork.com/view/fda-approves-ivosidenib-for-patients-with-idh1-positive-cholangiocarcinoma

https://www.targetedonc.com/view/ivosidenib-improves-overall-survival-in-advanced-idh1-cholangiocarcinoma

https://www.oncnursingnews.com/view/ivosidenib-maintains-quality-of-life-in-patients-with-cholangiocarcinoma

https://www.cancertherapyadvisor.com/home/cancer-topics/gastrointestinal-cancers/cholangiocarcinoma-idh1-ivosidenib-improve-survival-treatment-risk/

 

Copy link
WhatsApp
Facebook
Nextdoor
Email
X